CN102994650B - Multi-gene detection method of encephalitis viruses based on capillary electrophoresis - Google Patents

Multi-gene detection method of encephalitis viruses based on capillary electrophoresis Download PDF

Info

Publication number
CN102994650B
CN102994650B CN201210206611.2A CN201210206611A CN102994650B CN 102994650 B CN102994650 B CN 102994650B CN 201210206611 A CN201210206611 A CN 201210206611A CN 102994650 B CN102994650 B CN 102994650B
Authority
CN
China
Prior art keywords
pcr
reaction
primer
reverse transcription
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210206611.2A
Other languages
Chinese (zh)
Other versions
CN102994650A (en
Inventor
南丽
黄迎彬
吴勇
颜进
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ningbo Haier Shi Gene Technology Co.,Ltd.
Original Assignee
NINGBO HEALTH GENE TECHNOLOGIES Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NINGBO HEALTH GENE TECHNOLOGIES Co Ltd filed Critical NINGBO HEALTH GENE TECHNOLOGIES Co Ltd
Priority to CN201210206611.2A priority Critical patent/CN102994650B/en
Publication of CN102994650A publication Critical patent/CN102994650A/en
Application granted granted Critical
Publication of CN102994650B publication Critical patent/CN102994650B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a multi-gene detection method of encephalitis viruses based on capillary electrophoresis. The multi-gene detection method comprises the following steps: (1) producing a kit for multi-gene detection of the encephalitis viruses; (2) collecting a sample from a patient and extracting nucleic acid; (3) taking the nucleic acid of the patient as a template for performing reverse transcription; (4) taking a reverse transcription product as the template for performing PCR (polymerase chain reaction) reaction; and (5) separating the sample through a capillary electrophoresis method. The multi-gene detection method disclosed by the invention has the advantages of high sensitivity, good repeatability, strong accuracy, strong flexibility and low cost.

Description

A kind ofly cause encephalitis multiple gene detection method based on electrocapillary phoresis
Technical field
The present invention relates to a kind of detection method, especially a kind of highly sensitive, reproducible, accuracy is strong, handiness is strong, cost is low based on electrocapillary phoresis causes encephalitis multiple gene detection method.
Background technology
At present, China causes encephalitis detection main method has several as follows:
1. pathogenic examination: namely directly do image and examination of living tissue, or pathogen isolation is cultivated, and afterwards at microscope, electric Microscopic observation, makes diagnosis.This method had once been once the classical way of microorganism detection, and the basic platform of various detection method after being also, obtains the accreditation of every country, use till today in China always.Advantage: cost is low; Low to laboratory hardware requirement.Shortcoming: (1) length consuming time: generally need 3-5 days or longer.(2) diagnosis efficiency is low: can only single bacterium pure culture; To the pathogenic agent that some phenotypic characteristics make a variation, be difficult to distinguish by morphology experience; In addition, due to antibiotic abuse, bacterium grows and is suppressed in testing process, causes false-negative result.(3) workload is huge: owing to must detect often kind of bacterium of each sampling observation sample, workload is very huge, and particularly part requires comparatively harsh bacterium to culture environment, more increases workload and the difficulty of detection.
2. immunologic test: most widely used is Enzyme-multiplied immune technique (ELISA): generally first use primary antibodie and antigen generation specific binding, then with two anti-and primary antibodie generation specific bindings of general enzyme labelling, again enzyme is developed the color, observations afterwards.Advantage: (1) sample throughput is higher: utilize 96 hole enzyme plates, one flat plate can complete the detection of multiple sample; (2) more responsive: to utilize the characteristic that enzyme joins, original antigen signals can be amplified; (3) quick: in time, will to shorten much than traditional substratum microorganism culturing test procedure.Shortcoming: (1) easily occurs false positive: due to washing and antigen coated operation, or due to antigenic surface determinant similar and cross reaction occurs, therefore easily there is false positive; (2) take time and effort: making antibody is the work taken time and effort very much; (3) sensitivity is uncertain: the quality of antibody is depended in the sensitivity of experiment, and the quality of each antibody differs, and difficult quality controls; (4) virus of multi-Vari cannot be detected.
3. molecular biology-PCR detection method.At present often application has real-time fluorescence quantitative PCR, immuno-PCR, reverse transcription PCR etc., is all to detect for the specific target gene of pathogenic agent.Wherein, fluorescent quantitative PCR detection method is the most ripe.The advantage of fluorescent quantitative PCR technique: susceptibility is high, and can accurate quantification, in the detection to Listeria monocytogenes, Salmonellas, Clostridium botulinum, intestinal bacteria etc., all achieve good result.2004, China issued the national standard implementing fluorescence quantitative PCR detection bird flu H7 hypotype.2009, U.S. FDA have approved the test kit by fluorescence quantitative PCR detection porcine influenza H1N1 hypotype.The shortcoming of quantitative fluorescent PCR: (1) flux is low: once can only detect a cause of disease composition, as needs detect multiple pathogenic bacteria, just need multiple stage PCR instrument to work, efficiency is low simultaneously, cycle is long, has no way of doing it especially to the sample of large batch of multiple pathogen contamination; (2) cost is relatively high: because once detecting a pathogenic agent, and when a sample needs to detect multiple pathogenic bacteria simultaneously, must detect one by one, cost increases relatively.
4. molecular biology-gene chips: gene chip passes through micro-processing technology, by ten hundreds of and even 1,000,000 the DNA fragmentation (gene probe) of particular sequence, arrangement is fixed on the upholder such as silicon chip, slide regularly, the two-dimentional DNA probe array formed, utilize the biological sample of this kind of chip and mark to hybridize, fast qualitative and quantitative analysis can be carried out to the gene expression profile bioinformation of sample.Advantage: (1) high-flux parallel detects: when a sample needs to detect multiple pathogenic bacteria simultaneously, once experiment can draw whole result; (2) fast easy and simple to handle: whole detection only needs 4-8 hour substantially can go out result.Shortcoming: (1) technical costs is expensive, complicated: each sample needs a chip, and cost great Yu $1000/ sample, is unfavorable for large-scale promotion; The synthesis of probe and fixing more complicated, particularly make highdensity probe array, is main rate-limiting step; (2) can not accurate quantification, poor repeatability; (3) sensitivity is lower: chip method needs nucleic acid amount comparatively large, generally first must do multiplexed PCR amplification, because primer is more, easily self produces dimer, hairpin structure, or due to Tm value difference, and cause amplification object fragment efficiency different, and then the sensitivity that impact detects; (4) kind due to chip is more, is difficult to the quality control standard that formulation one is unified.
Summary of the invention
The object of this invention is to provide a kind of highly sensitive, reproducible, accuracy is strong, handiness is strong, cost is low multiple gene detection method causing encephalitis based on electrocapillary phoresis.
The present invention adopts following technical scheme:
Based on the multiple gene detection method causing encephalitis of electrocapillary phoresis, comprise the steps: that (1) produces " causing encephalitis multiple gene detection kit "; (2) gather Patient Sample A, and extract nucleic acid; (3) with patient's nucleic acid for template carries out reverse transcription; (4) be that template carries out PCR reaction with reverse transcription product; (5) with the method sample separation of electrocapillary phoresis.
Preferably, the test kit in described step (1) comprises: reverse transcription primer pipe, PCR primer pipe, reverse transcription buffer, PCR damping fluid, 25mM magnesium chloride, ThermoScript II, archaeal dna polymerase, fluorescent marker, positive control.
Preferably, the Patient Sample A in described step (2) comprises blood, cerebrospinal fluid etc.
Preferably, described step (3) comprise in sample panel, add reagent and sample and mixing in proportion after the sub-step of hatching at a certain temperature.
Preferably, the incubation temperature in described step (3) is respectively 48 DEG C, 42 DEG C, 95 DEG C, 4 DEG C.
Preferably, described step (4) comprise in sample panel, add reagent and sample and mixing in proportion after to carry out the sub-step of thermal cycle reaction by certain temperature.
Preferably, the thermal cycling temperature in the sub-step of described step (4) is respectively 95 DEG C, 94 DEG C, 60 DEG C, 70 DEG C, 4 DEG C.
Beneficial effect of the present invention is:
1. highly sensitive, reproducible: to adopt laser induced fluorescence(LIF)-PMT, there is hypersensitivity.
2. accuracy is strong: adopt capillary electrophoresis to carry out separation detection to PCR primer, non-specific amplification product, primer dimer can be separated with specific amplification products, at utmost reduce false positive.
3. high-throughput: native system adopts two (96 hole) plate, automatic sample and sample tracer technique, realize a single reaction detection 15-40 site, 192 reactions can be done (as 192 Patient Sample A simultaneously, each sample detection 14 kinds of pathogen of paying a home visit, 23 sites), within one day, go out result; For co-infected patients, present method disposablely can provide accurate report, avoids undetected.
4. accurate quantification: can accurate quantification pathogen gene copy number.
5. handiness is strong: the target gene that can adjust detection at any time according to demand.
6. cost is low: the testing cost Shao Yu $50 of each sample, is beneficial to large-scale promotion.
Embodiment
According to embodiment, the present invention is described in further detail below.
The virus detected comprises encephalitis b virus, fores encephalitis virus, Bo Wasen virus, west nile virus, hsv (I type and II type), varicella zoster virus, human cytomegalovirus, epstein-barr virus (EB), human herpes 6 C-type virus C, human herpes 7 C-type virus C, all enteroviruses, coxsackie virus A 16-type, enterovirns type 71, mumps virus, Measles virus, Nipah virus, rubella virus, rabies virus, adenovirus, human T-leukemia virus I type, human T-leukemia virus II type, lymphocyte train of thought meningitis virus etc. (table 1).
Cause the design of primers (see table 2 nucleotide sequence) that encephalitis multiple gene detects, for RNA template, sequence is added: 5 '-GTACGACTCACTATAGGGA-3 ', adds sequence in PCR primer: 5 ,-AGGTGACACTATAGAATA-3 ' at 5 ' end of RT primer; For DNA profiling, add sequence at 5 ' end of arbitrary primer: 5 '-GTACGACTCACTATAGGGA-3 ', adds sequence at another primer: 5 '-AGGTGACACTATAGAATA-3 '.To adapt to GeXP reaction system.
The target site that table 1 detects
Table 2 nucleotide sequence
Concrete steps are as follows:
1. produce " causing encephalitis multiple gene detection kit ", test kit comprises: reverse transcription primer pipe, PCR primer pipe, reverse transcription buffer, PCR damping fluid, 25mM magnesium chloride, ThermoScript II, archaeal dna polymerase, fluorescent marker, positive control.
2. gather Patient Sample A's (blood, cerebrospinal fluid etc.), and extract nucleic acid
3. with patient's nucleic acid for template carries out reverse transcription (RT):
1) in 96 hole sample panel, reagent and sample (RT plate) is added in following ratio:
Note: positive control: 1 μ L/ reacts
2) hatch by following temperature after mixing:
Step Temperature Time
1 48℃ 1 minute
2 42℃ 60 minutes
3 95℃ 5 minutes
4 4℃ Continue: until collect RT product
4. be that template carries out PCR reaction with reverse transcription product
1) in 96 hole sample panel, reagent and sample (PCR plate) is added in following ratio:
PCR reaction reagent Amount/hole
PCR damping fluid, 5X 4μL
25mM MgCl2 4μL
PCR primer 2μL
Archaeal dna polymerase 0.7μL
RT product 9.3μL
Total 20μL
2) thermal cycle reaction is carried out by following temperature after mixing:
Step Temperature Time
1 95℃ 10 minutes
2 94℃ 30 seconds
3 60℃ 30 seconds
4 70℃ 1 minute
5 N/A Repeat 2-4 step 34 time (totally 35 times)
6 70℃ 1 minute
7 4℃ Continue: until collect PCR primer
5. electrocapillary phoresis sample separation
1) GeXP sample is prepared:
GeXP sample Amount/hole
SLS sample solution 38.75μL
DNA size criteria 400 0.5μL
PCR primer 1μL
Total 40μL
Mineral oil 1
Note: PCR primer amount can be 0.1-1 μ L, or by loading after water on demand pre-dilution
2) parting liquid is prepared: added by about 220 μ L parting liquids in the hole of proper number on 96 hole parting liquid plates;
3) electrocapillary phoresis sample separation.
6. interpretation of result.
Obviously, the above embodiment of the present invention is only for example of the present invention is clearly described, and is not the restriction to embodiments of the present invention.For those of ordinary skill in the field, other multi-form change and variations can also be made on the basis of the above description.Here cannot give exhaustive to all embodiments.Every belong to technical scheme of the present invention the apparent change of amplifying out or variation be still in the row of protection scope of the present invention.

Claims (1)

1. the multiple gene detection kit causing encephalitis based on electrocapillary phoresis, it is characterized in that comprising: reverse transcription primer pipe, PCR primer pipe, reverse transcription buffer, PCR damping fluid, 25mM magnesium chloride, ThermoScript II, archaeal dna polymerase, fluorescent marker, positive control, RT primer in described reverse transcription primer pipe, people RNA internal reference and reaction internal reference concrete nucleotide sequence as shown in the table, the PCR primer in described PCR primer pipe, people DNA internal reference and reaction internal reference concrete nucleotide sequence specifically as shown in the table:
The middle quoted passage contrast detecting target is as shown in the table:
Join in 96 hole sample panel and carry out reverse transcription, reaction conditions after the wherein nucleic acid samples RNA 5uL of RT reaction system and reaction conditions: 5-20ng/ul, DEPC water 8uL, 5 × RT damping fluid 4uL, RT primer solution 2uL, RT enzyme 1uL mixing: 48 DEG C 1 minute; 42 DEG C 60 minutes; 95 DEG C 5 minutes; 4 DEG C until collect RT product;
PCR reaction system and reaction conditions: RT product 9.3uL, the magnesium chloride 4uL of 5 × PCR damping fluid 4uL, 25mM, joins the reaction of 96 hole sample panel enterprising performing PCR, reaction conditions after PCR primer solution 2uL, archaeal dna polymerase 0.7uL mixing: 95 DEG C 10 minutes; 94 DEG C of 30 second, 60 DEG C of 30 second, 70 DEG C 1 minute, circulate 34 times; 70 DEG C 1 minute; 4 DEG C until collect PCR primer.
CN201210206611.2A 2012-06-21 2012-06-21 Multi-gene detection method of encephalitis viruses based on capillary electrophoresis Active CN102994650B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210206611.2A CN102994650B (en) 2012-06-21 2012-06-21 Multi-gene detection method of encephalitis viruses based on capillary electrophoresis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210206611.2A CN102994650B (en) 2012-06-21 2012-06-21 Multi-gene detection method of encephalitis viruses based on capillary electrophoresis

Publications (2)

Publication Number Publication Date
CN102994650A CN102994650A (en) 2013-03-27
CN102994650B true CN102994650B (en) 2015-04-08

Family

ID=47923755

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210206611.2A Active CN102994650B (en) 2012-06-21 2012-06-21 Multi-gene detection method of encephalitis viruses based on capillary electrophoresis

Country Status (1)

Country Link
CN (1) CN102994650B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105385787B (en) * 2015-12-04 2020-02-14 南京美宁康诚生物科技有限公司 Multiple PCR detection kit for 12 encephalitis virus nucleic acids and application thereof
CN105821151A (en) * 2016-05-31 2016-08-03 四川金域医学检验中心有限公司 Detection method for multiplex genes
CN110066889B (en) * 2019-05-21 2023-11-24 四川国际旅行卫生保健中心 GeXP rapid detection primer group for simultaneously detecting four yellow fever viruses, kit and application thereof
CN111455115A (en) * 2020-05-27 2020-07-28 宁波海尔施基因科技有限公司 Kit and method for synchronously detecting 19 encephalitis meningitis pathogens based on RT-PCR and capillary electrophoresis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101245394B (en) * 2007-09-29 2011-01-26 谢鹏 Primer and probe of west nile virus and real time RT-PCR detection reagent kit with one-step method

Also Published As

Publication number Publication date
CN102994650A (en) 2013-03-27

Similar Documents

Publication Publication Date Title
CN103074450B (en) Kit for synchronously detecting thirty diarrhea pathogens and detection method of kit
Ambrosi et al. SARS-CoV-2: Comparative analysis of different RNA extraction methods
CN103074451B (en) Kit for synchronously detecting twenty-two respiratory tract pathogens and detection method of kit
Parida et al. Development and evaluation of reverse transcription loop-mediated isothermal amplification assay for rapid and real-time detection of the swine-origin influenza A H1N1 virus
CN103074449B (en) Kit for synchronously detecting thirteen diarrhea viruses and detection method of kit
CN103074448B (en) Kit for synchronously detecting twenty-three meningitis pathogens and detection method of kit
CN103397107B (en) Bovine viral diarrhea virus (BVDV) fluorescent quantitative RT-PCR (reverse transcription-polymerase chain reaction) detection kit
CN103074452B (en) Kit for synchronously detecting fifteen hemorrhagic fever pathogens and detection method of kit
Yang et al. Development and evaluation of a reverse transcription loop-mediated isothermal amplification assay for rapid detection of a new SFTS bunyavirus
CN104561377A (en) Real-time fluorescent multiplex PCR (polymerase chain reaction) based kit for rapidly detecting common respiratory pathogens
CN110106290A (en) A kind of field fast detection method and kit being used to detect ASFV based on CRISPR/Cas system
CN103614489B (en) Constant-temperature amplification detection kit for dengue viruses and detection method
CN106868220A (en) A kind of LAMP primer group and kit for expanding MERS CoV
CN102994650B (en) Multi-gene detection method of encephalitis viruses based on capillary electrophoresis
Wang et al. Visual detection of porcine epidemic diarrhea virus using a novel reverse transcription polymerase spiral reaction method
CN106222298B (en) LAMP detection kit, detection method and application of RNA virus
CN114262759A (en) PCR primer group and kit for combined detection of multiple respiratory viruses
CN108977578A (en) Detect the kit and its method of H7N9 avian influenza virus
Li et al. Development of a multiplex real-time polymerase chain reaction for the detection of influenza virus type A including H5 and H9 subtypes
CN103146841B (en) Kit capable of synchronously detecting eighteen kinds of fever with eruption pathogens and detection method thereof
Hockman et al. Comparison of multiplex PCR hybridization-based and singleplex real-time PCR-based assays for detection of low prevalence pathogens in spiked samples
Vandemeulebroucke et al. A proposed validation method for automated nucleic acid extraction and RT-qPCR analysis: An example using Bluetongue virus
CN112410465A (en) Novel coronavirus SARS-CoV-2ORF1ab and N gene constant temperature amplification primer group and kit
CN105063228B (en) The detection kit and detection method of a kind of flavobacterium columnare
CN102994649A (en) Multi-gene detection method of rash pathogens based on capillary electrophoresis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: NINGBO HEALTH GENE TECHNOLOGIES CO., LTD.

Free format text: FORMER OWNER: HEALTH BIOMEDICAL CO., LTD.

Effective date: 20150217

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20150217

Address after: 315000 No. 396 Mingzhu Road, science and Technology Park, Zhejiang, Ningbo

Applicant after: NINGBO HEALTH GENE TECHNOLOGIES CO., LTD.

Address before: Kaohsiung streets 315000 Zhejiang city of Ningbo province advance port No. 159 West

Applicant before: Health Biological Medicine Co., Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: 315000 No.396, Mingzhu Road, science and Technology Park, Ningbo City, Zhejiang Province

Patentee after: Ningbo Haier Shi Gene Technology Co.,Ltd.

Address before: 315000 No.396, Mingzhu Road, science and Technology Park, Ningbo City, Zhejiang Province

Patentee before: Ningbo Health Gene Technologies Co.,Ltd.